Single-dose etomidate does not increase mortality in patients with sepsis: a systematic review and meta-analysis of randomized controlled trials and observational studies.
@article{Gu2015SingledoseED, title={Single-dose etomidate does not increase mortality in patients with sepsis: a systematic review and meta-analysis of randomized controlled trials and observational studies.}, author={Wan-Jie Gu and Fei Wang and Lu Tang and Jing-chen Liu}, journal={Chest}, year={2015}, volume={147 2}, pages={ 335-346 } }
BACKGROUND
The effect of single-dose etomidate on mortality in patients with sepsis remains controversial. We systematically reviewed the literature to investigate whether a single dose of etomidate for rapid sequence intubation increased mortality in patients with sepsis.
METHODS
PubMed, Embase, and CENTRAL (Cochrane Central Register of Controlled Trials) were searched for randomized controlled trials (RCTs) and observational studies regarding the effect of single-dose etomidate on mortality…
Figures and Tables from this paper
98 Citations
Evaluation of dexmedetomidine versus propofol sedation therapy in mechanically ventilated cardiac surgery patients : a systematic review and meta-analysis of randomized controlled trials and observational studies
- Medicine
- 2016
Current evidences demonstrate that dexmedetomidine decreases the duration of MV in cardiac surgery patients, Nevertheless, most results relying on the data from observational studies only might cause the selection bias.
Anesthetic Induction With Etomidate in Cardiac Surgical Patients: A PRISMA-Compliant Systematic Review and Meta-Analysis.
- MedicineJournal of cardiothoracic and vascular anesthesia
- 2020
It is suggested that single-dose ETM during anesthetic induction could be associated with more stable hemodynamics, transient and reversible lower cortisol levels, and a higher adrenal insufficiency incidence, but not worse outcomes in cardiac surgical patients.
The use of etomidate for rapid sequence induction in septic patients.
- MedicineJournal of thoracic disease
- 2015
The recent meta-analysis by Gu et al. provides an accurate and complete assessment of the existing literature on this topic and concludes that etomidate is still utilized for the purposes of RSI in this critically ill patient population and the current data supports this position.
Etomidate, Adrenal Insufficiency and Mortality Associated With Severity of Illness: A Meta-Analysis
- MedicineJournal of intensive care medicine
- 2020
Whereas etomidate causes adrenal insufficiency, it was not shown to increase mortality in many analyzed here in ICU settings, however, etomidates associated relative mortality rates increased progressively and correlated with the severity of critical illness scores.
Mortality attributable to carbapenem-resistant Pseudomonas aeruginosa bacteremia: a meta-analysis of cohort studies
- Biology, MedicineEmerging Microbes & Infections
- 2016
The results were robust across a number of stratified analyses and a sensitivity analysis, and Carbapenem resistance had a deleterious impact on the mortality of P. aeruginosa bacteremia; however, the results should be interpreted cautiously because only three studies reporting adjusted ORs were included.
Statin use and risk of tuberculosis: A systemic review of observational studies.
- MedicineInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
- 2020
Comparison of mono- and combination antibiotic therapy for the treatment of Pseudomonas aeruginosa bacteraemia: A cumulative meta-analysis of cohort studies
- Medicine, BiologyExperimental and therapeutic medicine
- 2018
Neither combination therapy or monotherapy exhibited significant effects on the mortality of patients with P. aeruginosa bacteraemia, and future research is required to include large, well-designed prospective cohorts, and grouped clinical studies.
Association between Etomidate Use for Rapid Sequence Intubation and Adrenal Insufficiency in Sepsis
- MedicineCureus
- 2021
A trend was shown, although not statistically significant, towards the development of AI in septic patients, and in the subset of patients who received etomidate for RSI, there was a non-significant trend toward increased incidence of AI.
Association between time of discharge from ICU and hospital mortality: a systematic review and meta-analysis
- Medicine, BiologyCritical Care
- 2016
Nighttime ICU discharge is associated with an increased risk of hospital mortality, while weekend ICU discharged is not, and these conclusions should be interpreted with caution, and should be tested in further studies.
Comparison of Drug‐Eluting and Bare Metal Stents in Patients With Chronic Kidney Disease: An Updated Systematic Review and Meta‐Analysis
- MedicineJournal of the American Heart Association
- 2016
The use of DESs significantly improves the above outcomes in CKD patients and whether efficacy differs by type of DES, and the superiority ofDESs over BMSs for improving clinical outcomes was attenuated in randomized controlled trials.
References
SHOWING 1-10 OF 48 REFERENCES
Etomidate is associated with mortality and adrenal insufficiency in sepsis: A meta-analysis*
- MedicineCritical care medicine
- 2012
Administration of etomidate for rapid sequence intubation is associated with higher rates of adrenal insufficiency and mortality in patients with sepsis.
Single-Dose Etomidate Is Not Associated With Increased Mortality in ICU Patients With Sepsis: Analysis of a Large Electronic ICU Database*
- MedicineCritical care medicine
- 2013
In a mixed-diagnosis group of critically ill patients with sepsis, severe sepsi, and septic shock, single-dose etomidate administration for intubation in the ICU was not associated with higher mortality, shock, duration of mechanical ventilation, ICU or hospital length of stay, or vasopressor use.
Low-Dose Hydrocortisone Therapy Attenuates Septic Shock in Adult Patients but Does Not Reduce 28-Day Mortality: A Meta-Analysis of Randomized Controlled Trials
- Medicine, BiologyAnesthesia and analgesia
- 2014
Although low-dose hydrocortisone therapy ameliorates septic shock at 7 and 28 days, it does not reduce 28-day mortality.
A comparison of the effects of etomidate and midazolam on hospital length of stay in patients with suspected sepsis: a prospective, randomized study.
- MedicineAnnals of emergency medicine
- 2010
Effects of etomidate on vasopressor use in patients with sepsis or severe sepsis: a propensity-matched analysis.
- Medicine, BiologyJournal of critical care
- 2014
A prospective observational study of the effect of etomidate on septic patient mortality and length of stay.
- MedicineAcademic emergency medicine : official journal of the Society for Academic Emergency Medicine
- 2009
No statistically significant increase in hospital LOS or mortality in patients given etomidate for rapid-sequence intubation was found, and suggestions that the use of etomidates for intubated patients in the emergency department be abandoned are not supported.
Effects of etomidate on complications related to intubation and on mortality in septic shock patients treated with hydrocortisone: a propensity score analysis
- MedicineCritical Care
- 2012
In septic shock patients treated with hydrocortisone, etomidate did not decrease life-threatening complications following intubation, but when associated with hydrodisone it also did not impair outcome.
Etomidate use in severe sepsis and septic shock patients does not contribute to mortality
- MedicineInternal and emergency medicine
- 2011
This large retrospective multi-center study further supports the safety of etomidate use in severe sepsis and septic shock by finding no significant difference in mortality between etomidates and non-etomidate cohorts in this study.
The effects of etomidate on adrenal responsiveness and mortality in patients with septic shock
- Medicine, BiologyIntensive Care Medicine
- 2009
The use of bolus dose etomidate in the 72 h before study inclusion is associated with an increased incidence of inadequate response to corticotropin, but is also likely to be associated with a increase in mortality.
Corticosteroid after etomidate in critically ill patients: A randomized controlled trial*
- Medicine, BiologyCritical care medicine
- 2012
It is suggested that critically ill patients without septic shock do not benefit from moderate-dose hydrocortisone administered to overcome etomidate-related adrenal insufficiency.